Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CNOT8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRIM27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM160A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MLX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TYW5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PWP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MRPS27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABHD12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYO9A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APEX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NRDC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LIG4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DXO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on